Judge: Bruce G. Iwasaki, Case: 24STCV21291, Date: 2025-06-04 Tentative Ruling
Case Number: 24STCV21291 Hearing Date: June 4, 2025 Dept: 14
SUPERIOR COURT OF THE STATE OF
CALIFORNIA¿¿
FOR THE COUNTY OF LOS ANGELES
DEPARTMENT 14¿
¿
|
TERRY LUHR, et al., Plaintiffs¿ v. 3M COMPANY, et al.., ¿ Defendants.¿¿ |
Case No. 24STCV21291 ¿¿¿¿ Hearing Date: June 4, 2025
Time:
9:00 a.m. ¿ [TENTATIVE] ORDER
RE:¿ PLAINTIFFS’ MOTION FOR TRIAL SETTING
PREFERENCE |
On August 20, 2024, Plaintiffs Terry and Ann Luhr (“Plaintiffs”) filed
their complaint for personal injury alleging that Mr. Luhr developed
mesothelioma from exposure to asbestos and asbestos-containing products through
his work as a drywaller and auto mechanic from the 1960s to the 1980s.
On May 8, 2025, Plaintiffs filed a motion for trial setting preference
under Code of Civil Procedure section 36, subdivision (a). On May 21, 2025, Defendants
Genuine Parts Company and Amcord, Inc. filed conditional non-opposition to
Plaintiffs motion. The same day, Defendants the Dunn Edwards Corporation, the
Sherwin Williams Company, Pneumo Abex LLC, and Dixieline Lumber Company filed
opposition. Defendants Swinerton Builders and American Biltrite Inc. joined in
the other Defendants’ opposition. Of these opposing Defendants, only Defendant The
Sherwin Williams Company substantively opposes Plaintiffs’ motion under the
36(a) standard arguing Plaintiffs fail to present sufficient evidence that Mr.
Luhr’s health is such that preference is necessary to prevent prejudicing
Plaintiffs’ interest in the litigation. The remaining opposing Defendants
primarily argue that the court has inherent power under the JCCP to deny
Plaintiffs’ motion. On May 28, 2025, Plaintiffs filed their reply. On June 4,
2025, the court held a hearing.
The court grants Plaintiffs’ motion for trial preference.
A party who is over 70 years old may petition the court for a preference
for trial date, which the court shall grant if it makes both of the following
findings: (1) the party has a substantial interest in the action as a whole;
and (2) the health of the party is such that a preference is necessary to
prevent prejudicing the party’s interest in the litigation. (Code Civ. Proc., §
36, subd. (a).) An affidavit submitted in support of a motion for preference
under this subdivision may be signed by the attorney for the party seeking
preference based upon information and belief as to the medical diagnosis and
prognosis of any party. (Id., § 36.5.)
“Upon the granting of such a motion for preference, the court shall set
the matter for trial not more than 120 days from that date and there shall be
no continuance beyond 120 days from the granting of the motion for preference
except for physical disability of a party or a party’s attorney, or upon a
showing of good cause stated in the record.”
(Code. Civ. Pro., § 36, subd. (f).)
“Any continuance shall be for no more than 15 days and no more than one
continuance for physical disability may be granted to any party.” (Ibid.)
Plaintiff Terry Luhr is 75
years old and was diagnosed with malignant lung cancer in June 2023. (Pearce
Decl. ¶ 4.) Mr. Timothy Pearce, Plaintiffs’ attorney, opines: “Based upon
information and belief, and my decades of experience in representing cancer
victims, Mr. Luhr’s health will continue to decline as his cancer progresses.
He will inevitably become increasingly weak and his severe coughing bouts will
increase and worsen, along with the above-described physical and mental effects
that stem therefrom. [¶] Based upon my experience and my conversations with Mr.
Luhr, it is my opinion that Mr. Luhr’s declining health and age may negatively
affect and/or greatly impair his ability to participate in the litigation of
his personal injury action.” (Pearce Decl. ¶¶ 8-9.) Mr. Pearce bases his
opinion on approximately 50 hours of conversations and interactions with Mr.
Luhr since August of 2024, and a recent change to Mr. Luhr’s diagnosis. (Pearce
Decl. ¶ 7 [“Since meeting Mr. Luhr nine months ago, I have seen a marked
decline in his ability to concentrate, maintain conversation, and recall events.”].)
Specifically, while Mr. Luhr was originally diagnosed with “Stage 1a” cancer in
June 2023, as of February 18, 2025, a PET/CT scan revealed that his cancer had
metastasized to his bones and his liver such that his cancer is now considered
stage IV. (Pearce Decl. ¶ 4; Ex. 1 at p. 2 [“Reviewed recent PET/CT. He has metastatic disease to the bones and the liver. This was confirmed on biopsy of liver mass
although unclear if this is now a small cell lung cancer.
Finally, Mr. Pearce describes Mr. Luhr’s current symptoms as follows: “Mr. Luhr
can only speak for about an hour and a half before it becomes too exhausting
for him and he cannot continue. Since initially meeting Mr. Luhr about nine (9)
months ago, I have witnessed an increase in the frequency and intensity of his
coughing fits. I observed his coughing and exhaustion cause him great physical
and mental strain as it impairs Mr. Luhr’s ability to focus, concentrate, and
communicate, making him less likely to be able to effectively participate in
anything in his life in a meaningful way, specifically and inherently including
in the trial of his case, the more time passes. Mr. Luhr has
expressed that he is increasingly fatigued and experiencing some depression. He
has further expressed deep concern for his wife’s well-being after his death
and wants to see justice, i.e., his trial, in his lifetime.” (Pearce Decl. ¶
6.)
Plaintiffs also
attach to Mr. Pearce’s declaration excerpts of of Mr. Luhr’s deposition taken
on March 26, 2025 in which he describes his current health. (Pearce Decl. Ex. 2.)
In pertinent part Mr. Luhr states: “My current condition is that, after
undergoing radiation to treat the first round of cancer, it has returned. It's
metastasized in the liver and some in the bone, and I'm currently undergoing
chemo and immunotherapy for that. (Id. at 9:18-22.) He further describes
his current understanding of his prognosis: “my doctor has said -- he said,
let's go through -- at the beginning of May, we'll do another CT scan on you
and see if the cancer has shrunk, or see if we're making any progress and we'll
reevaluate from there.” (Id. at 92:21-24.)
The opposing Defendants do not dispute that Mr. Johnson
is above the statutory age threshold or that Plaintiffs have a substantial
interest in the litigation. Instead, Sherwin-Williams argues that Plaintiffs fail
to present sufficient evidence to show that Mr. Luhr’s health is such that
preference is necessary to prevent prejudicing Plaintiffs’ interest in the
litigation. Sherwin-Williams argues: “Nothing in Plaintiffs’ Motion or the
accompanying declaration of Plaintiffs’ counsel, shows that Mr. Luhr’s health
has changed or declined since the filing of Plaintiffs’ Complaint (or even his
initial diagnosis in June of 2023). Plaintiffs’ lawyer’s attestations do not
convincingly demonstrate that Mr. Luhr’s health would decline so suddenly and
substantially that he could not participate in litigation based on his current
diagnoses.” (Sherwin-Williams Opposition at p. 4.) Sherwin-Williams further
argues: “Mr. Pearce’s declaration and the non-expert opinions contained therein
lacks foundation and at times, are plainly inaccurate. Even if accurate, it
does not provide this Court with any information regarding Mr. Luhr’s current
health condition or life prognosis. Mr. Luhr even testified that he was not
told about a prognosis. Instead, his doctors have a ‘wait and see’ approach to
determine his next course of treatment only after his next CT scan in May. This
means that Mr. Luhr’s condition could actually improve. Regardless, nowhere in
the Motion states Mr. Luhr’s illness is incurable or terminal and Plaintiffs’
Motion simply does not provide this Court with the information necessary to
conclude that Mr. Luhr’s current medical status rises to the level of the Code
Civ. Proc. section § 36(a) requirements. As the trained medical professionals
recommend, the Court should also take a ‘wait and see’ approach, see what the
results of the May CT scan reflect, and hold on ruling on the motion for
preference until that time.” (Id. at p. 6.) Sherwin-Williams also
directs the court’s attention to the fact Mr. Luhr was a smoker from 1970 to
2023. (Id. at p. 2 [“Take note that the medical records provided by
Plaintiffs in support of their Motion and responses to LAOSD standard
interrogatories confirm Mr. Luhr’s 50+ year smoking history. Mr. Luhr smoked
from 1970, up until 2023 (ie the year of his lung cancer diagnosis), at a pack
and a half of cigarettes per day.”].)
In reply, Plaintiffs argue they present sufficient
evidence to satisfy their burden. Plaintiffs argue: “No opposing Defendant
offers any evidence in support of their position that Plaintiff should not be
granted a trial in less than 120 days. The fact remains that Mr. Luhr is now
almost 76 years old and rapidly dying of malignant metastatic lung cancer that
has aggressively spread to his liver and bones in a matter of just a few
months. Mr. Luhr has increased coughing fits which causes difficulty breathing.
He suffers increasing fatigue, is increasingly drained both physically and
mentally, rendering him focus-challenged. He is less and less able to
participate in activities he enjoys and is experiencing depression. His current
treatment leaves him in extreme pain and with difficulty sleeping. His health
will continue to decline, and so too will his mental capacity and thus ability
to recall and engage in his trial. Unfortunately for Mr. Luhr, these facts have
not and will not change.” (Reply at p. 3.) Plaintiffs also argue that Mr.
Luhr’s history of smoking is irrelevant to this motion. (Id. at pp. 2-3
[“defendant presents a dishonest picture for this Court by ignoring the
evidence before it and attempting to imply that Mr. Luhr’s smoking history has
some negative bearing on his ability to obtain a preferential trial date – as
if some unidentified law prevents a former smoker, who is actively dying, from
bringing a motion under CCP 36. It is offensive.”].)
The evidence before the court
is sufficient to establish that Plaintiffs are entitled to a trial preference
under Code of Civil Procedure section 36 subdivision (a). There is no dispute
that Mr. Luhr’s age is above the threshold required under the statute and that he
has a substantial interest in the litigation. There is also sufficient evidence
to show Mr. Johnson’s health is such that preference is necessary to prevent
prejudicing Plaintiffs’ interest in the litigation. There is substantial
evidence from the declaration of Mr. Pearce and the attached medical records
that Mr. Luhr recently received a diagnosis which will greatly impact his
health and prognosis. It is undisputed that Mr. Luhr has stage IV metastatic
cancer, and that cancer has spread to his liver and his bones. (Pearce Decl.
Ex. 1 at p. 2.) Mr. Pearce and Mr. Luhr both describe changes to his health
since he was first diagnosed with cancer, and how those symptoms have changed
since he began more vigorous treatment to address this more aggressive form of
cancer. (See Pearce Decl. ¶ 6, Ex. 2, Luhr depo, at 89:22-24 [“Well, at first
it was the radiation treatment, which I managed to get through fairly well, and
now this chemo is kind of kicking my butt.”].) Defendant’s arguments that Mr.
Luhr’s medical records and deposition testimony are inconsistent with My.
Pearce’s May 7, 2025 declaration are misplaced. Mr. Pearce’s declaration is the
most up to date evidence submitted in this case. It is entirely consistent with
the progression of illness that Mr. Luhr would not report as severe symptoms to
his doctor in February or during a deposition in March as he is experiencing in
May. Defendant does not present any contrary expert testimony to interpret Mr. Luhr’s
medical records or deposition testimony and instead relies exclusively on the
arguments of counsel. Mr. Luhr’s course of illness establishes his health is
likely to prejudice Plaintiffs’ interest in the future if trial preference is
not granted. Therefore, the court finds Plaintiffs satisfy their burden.
Plaintiffs’ motion for
trial setting preference is granted. The court orders the parties to meet and
confer regarding the appropriate conditions for a trial setting order. The
court sets a status conference regarding the trial setting order for June 25,
2025 at 9 A.M. The court sets a final status conference for September 15, 2025
at 9 A.M. The court sets trial for Monday September 29, 2025 at 9 A.M [117 Days].